Dimensional Fund Advisors’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding GLUE
Dimensional Fund Advisors's GLUE Position: Q3 2026 in Review
Dimensional Fund Advisors increased its Monte Rosa Therapeutics (GLUE) stake by 17% in Q3 2026, buying an estimated $3.49M and bringing the position to 1,381,344 shares worth $16.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2103.
Dimensional Fund Advisors first reported a position in GLUE in Q1 2023 and has held it in 15 quarters since. The position peaked at $28.5M in Q2 2026. 39 funds tracked by Wall St. Rank hold GLUE as of Q3 2026.
- Dimensional Fund Advisors held 1,381,344 shares of Monte Rosa Therapeutics worth $16.5M as of Q3 2026.
- Dimensional Fund Advisors bought 203,856 Monte Rosa Therapeutics shares in Q3 2026, an estimated $3.49M.
- Monte Rosa Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2103 holding.
- Dimensional Fund Advisors first reported a position in Monte Rosa Therapeutics in Q1 2023 and has held it in 15 quarters since.
- Dimensional Fund Advisors's Monte Rosa Therapeutics position peaked at $28.5M in Q2 2026.
- 39 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q3 2026.
Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.